A PET study to determine biodistribution and binding characteristics of [11^C]AZ14132516 in healthy participants

Trial Identifier: D9690C00003
Sponsor: AstraZeneca
NCTID:: NCT05818514
Start Date: April 2023
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Swedish Translation

Trial Locations

Country Location
SE Solna, SE, 171 64